Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Depressive Symptoms Linked to Motoric Cognitive Risk

May 5, 2026
Continue Reading
depressive-symptoms-linked-to-motoric-cognitive-risk
Posted inBiotechnology

Predicting Coronary Artery Aneurysms in Kawasaki Disease

May 5, 2026
Continue Reading
predicting-coronary-artery-aneurysms-in-kawasaki-disease
Posted inBiotechnology

Breakthrough Study Advances Personalized Treatment for Parkinson’s Disease

May 5, 2026
Continue Reading
breakthrough-study-advances-personalized-treatment-for-parkinson’s-disease
Posted inBiotechnology

School Fitness Testing: Challenges and New Opportunities

May 5, 2026
Continue Reading
school-fitness-testing:-challenges-and-new-opportunities
Posted inBiotechnology

ZNF473 Drives Colorectal Cancer, Boosts Chemoresistance

May 5, 2026
Continue Reading
znf473-drives-colorectal-cancer,-boosts-chemoresistance
Posted inBiotechnology

All-Metal Biodegradable Microrobots Set to Revolutionize Drug Delivery and Biopsy Techniques

May 5, 2026
Continue Reading
all-metal-biodegradable-microrobots-set-to-revolutionize-drug-delivery-and-biopsy-techniques
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More
regeneron-anticoagulant-bests-enoxaparin,-matches-eliquis-in-phase-2-trial
Posted inBiotechnology

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial

December 19, 2024
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…
Read More
vertex’s-pain-trial-hits-endpoint-but-sinks-stock-as-placebo-comparison-spooks-investors
Posted inBiotechnology

Vertex’s pain trial hits endpoint but sinks stock as placebo comparison spooks investors

December 19, 2024
Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the near-approval…
Read More
electrocore-to-buy-neurometrix-and-its-quell-fibromyalgia-wearable-stimulator
Posted inMedical Technology

ElectroCore to buy NeuroMetrix and its Quell fibromyalgia wearable stimulator

December 19, 2024
Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and…
Read More
uncovering-craniopharyngioma’s-growth-mechanism-may-identify-new-therapy
Posted inGenetics

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy

December 19, 2024
Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…
Read More

Posts pagination

Previous page 1 … 1,770 1,771 1,772 1,773 1,774 … 1,784 Next page
You May Have Missed
nuvalent-teams-up-with-guardant-health-for-companion-diagnostics
Posted inMedical Technology

Nuvalent teams up with Guardant Health for companion diagnostics

genomics-inks-partnership-deal-with-greywolf-to-assess-gene-datasets
Posted inMedical Technology

Genomics inks partnership deal with Greywolf to assess gene datasets

labcorp-raises-full-year-guidance,-boosted-by-diagnostics,-lab-services
Posted inMedical Technology

Labcorp raises full-year guidance, boosted by diagnostics, lab services

caredx-expands-into-cancer-testing-with-$260m-naveris-buy
Posted inMedical Technology

CareDx expands into cancer testing with $260M Naveris buy

Privacy Policy    Terms

Scroll to Top